LinkedIn·Friday, 14 August 2026·12d ago

𝗧𝗲𝗮𝗰𝗵𝗶𝗻𝗴 𝗔𝗜 𝗕𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰𝗶𝘁𝘆 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲𝘀 𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 Designing…

ePotentia

211 followers

𝗧𝗲𝗮𝗰𝗵𝗶𝗻𝗴 𝗔𝗜 𝗕𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰𝗶𝘁𝘆 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗲𝘀 𝗔𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 Designing effective therapeutic antibodies requires searching through millions or billions of candidates to find rare, high-affinity binders. Boston University researchers have developed a targeted AI framework that narrows this search by training directly on antibody biology rather than relying on massive, generalized protein models. 𝗙𝗼𝗰𝘂𝘀𝗶𝗻𝗴 𝗼𝗻 𝗕𝗶𝗻𝗱𝗶𝗻𝗴 𝗟𝗼𝗼𝗽𝘀 𝗢𝘃𝗲𝗿 𝗠𝗼𝗱𝗲𝗹 𝗦𝗰𝗮𝗹𝗲 Most antibody structures serve as generic scaffolding, while target binding occurs almost entirely within six small loops known as complementarity-determining regions (CDRs). Published in Communications AI & Computing, the study describes a 600-million-parameter model that masks up to half the amino acids in these CDR loops during training. By prioritizing domain-specific biological patterns over sheer model scale, the framework improved binding affinity predictions by up to 27 percent while using significantly fewer computational resources. 𝗦𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗶𝗻𝗴 𝗟𝗮𝗯𝗼𝗿𝗮𝘁𝗼𝗿𝘆 𝗪𝗼𝗿𝗸𝗳𝗹𝗼𝘄𝘀 By accurately predicting binding strength prior to wet-lab evaluation, the tool narrows trillions of potential sequence variants down to the most viable candidates. This approach reduces unnecessary lab testing, speeds up therapeutic optimization against evolving viral targets, and demonstrates that smaller, biologically informed AI models can outperform generic architectures in specialized drug discovery. https://lnkd.in/edSfbYk6

View on LinkedIn